Nisa Investment Advisors
HBIO icon

Nisa Investment Advisors’s Harvard Bioscience HBIO Stock Holding History

Nisa Investment Advisors’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4K Hold
228
– – ﹤0.01% 2809
2026
Q1 		$1.11K Sell
228
-1
-0.4% -$6 ﹤0.01% 2729
2025
Q4 		$1.53K Hold
229
– – ﹤0.01% 2653
2025
Q3 		$1K Hold
229
– – ﹤0.01% 2747
2025
Q2 		$1.02K Buy
229
+177
+340% +$740 ﹤0.01% 2734
2025
Q1 		$297 Sell
52
-9
-15% -$115 ﹤0.01% 2873
2024
Q4 		$1.29K Buy
61
+58
+1,933% +$1.33K ﹤0.01% 2611
2024
Q3 		$83 Sell
3
-10
-77% -$295 ﹤0.01% 2917
2024
Q2 		$382 Buy
+13
New +$456 ﹤0.01% 2737

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $118M AUM
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nisa Investment Advisors's HBIO Position: Q2 2026 in Review

Nisa Investment Advisors held its Harvard Bioscience (HBIO) position steady in Q2 2026 at 228 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

Nisa Investment Advisors first reported a position in HBIO in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.53K in Q4 2025. 37 funds tracked by Wall St. Rank hold HBIO as of Q2 2026.

  • Nisa Investment Advisors held 228 shares of Harvard Bioscience worth $1.4K as of Q2 2026.
  • Nisa Investment Advisors left its Harvard Bioscience share count unchanged in Q2 2026.
  • Harvard Bioscience made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2809 holding.
  • Nisa Investment Advisors first reported a position in Harvard Bioscience in Q2 2024 and has held it in 9 quarters since.
  • Nisa Investment Advisors's Harvard Bioscience position peaked at $1.53K in Q4 2025.
  • 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.